ஆஸ்துமா மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Last Updated: Asthma Drug Shortens Recovery Time In Non-hospitalised COVID-19 Patients: Study A landmark study recently found that an inhaled drug commonly used for asthma shortens the recovery time of COVID-19 sufferers who do need hospital treatment. Image: AP/Pixabay A landmark study recently found that an inhaled drug commonly used for asthma shortens the recovery time of COVID-19 sufferers who do need hospital treatment. According to the result from the Principle trial, British scientists from Oxford University found that budesonide, which is an anti-inflammatory medicine, can help accelerate recovery in the over 50s by an average of three days. The researchers said that the readily available drug, administered via a cheap inhaler twice a day for up to 14 days, can be prescribed through general practitioners, raising hope that doctors will be able to start treating COVID-19 patients at home early in their illness. 

United kingdomGail haywardChris butlerOxford universityProfessor gail haywardAsthma drugCovid 19Covid recoveryஒன்றுபட்டது கிஂக்டம்கெயில் வைக்கோல்கிறிஸ் பட்லர்ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம்ப்ரொஃபெஸர் கெயில் வைக்கோல்ஆஸ்துமா மருந்து